| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CELGENE CORP | 199,650 | 23,109,000 | 4.73% | ||
| 2 | STRYKER CORP | 155,400 | 18,618,000 | 3.81% | ||
| 3 | MEDTRONIC PLC | 259,500 | 18,484,000 | 3.79% | ||
| 4 | UNITEDHEALTH GROUP INC | 110,000 | 17,604,000 | 3.61% | ||
| 5 | ABBOTT LABS | 405,500 | 15,575,000 | 3.19% | ||
| 6 | INCYTE | 150,400 | 15,081,000 | 3.09% | ||
| 7 | BIOGEN INC | 49,000 | 13,895,000 | 2.85% | ||
| 8 | GILEAD SCIENCES INC | 179,500 | 12,854,000 | 2.63% | ||
| 9 | LIGAND PHARMACEUTICALS INC | 124,530 | 12,653,000 | 2.59% | ||
| 10 | AMGEN INC | 83,500 | 12,209,000 | 2.50% | ||
| 11 | BOSTON SCIENTIFIC CORP | 550,000 | 11,896,000 | 2.44% | ||
| 12 | REGENERON PHARMACEUTICALS | 32,300 | 11,857,000 | 2.43% | ||
| 13 | EDWARDS LIFESCIENCES CORP | 125,000 | 11,712,000 | 2.40% | ||
| 14 | BARD C R INC | 51,100 | 11,480,000 | 2.35% | ||
| 15 | ZIMMER BIOMET HLDGS INC | 103,000 | 10,630,000 | 2.18% | ||
| 16 | AKORN INC | 460,000 | 10,042,000 | 2.06% | ||
| 17 | JAZZ PHARMACEUTICALS PLC SHS USD | 83,800 | 9,137,000 | 1.87% | ||
| 18 | MYLAN N V | 235,700 | 8,992,000 | 1.84% | ||
| 19 | HOLOGIC INC | 219,600 | 8,810,000 | 1.80% | ||
| 20 | CENTENE CORP DEL | 151,630 | 8,569,000 | 1.75% | ||
| 21 | TEVA PHARMACEUTICAL INDS LTD | 234,990 | 8,518,000 | 1.74% | ||
| 22 | BAXTER INTL INC | 190,000 | 8,425,000 | 1.73% | ||
| 23 | ILLUMINA INC | 53,800 | 6,889,000 | 1.41% | ||
| 24 | BECTON DICKINSON & CO | 40,000 | 6,622,000 | 1.36% | ||
| 25 | ALLERGAN PLC | 29,400 | 6,174,000 | 1.26% | ||
| 26 | ALEXION PHARMACEUTIC | 49,400 | 6,044,000 | 1.24% | ||
| 27 | VERTEX PHARMACEUT | 81,000 | 5,967,000 | 1.22% | ||
| 28 | DANAHER CORP DEL | 74,000 | 5,760,000 | 1.18% | ||
| 29 | INTUITIVE SURGICAL INC | 9,000 | 5,708,000 | 1.17% | ||
| 30 | BIOMARIN | 65,000 | 5,385,000 | 1.10% | ||
| 31 | ABIOMED INC | 45,050 | 5,076,000 | 1.04% | ||
| 32 | CIGNA CORPORATION | 37,722 | 5,032,000 | 1.03% | ||
| 33 | COHERUS BIOSCIENCES INC COM | 175,000 | 4,926,000 | 1.01% | ||
| 34 | CERNER CORP | 98,500 | 4,666,000 | 0.96% | ||
| 35 | ARIAD PHARMACEUTICALS INC | 375,000 | 4,665,000 | 0.96% | ||
| 36 | JOHNSON & JOHNSON | 38,000 | 4,378,000 | 0.90% | ||
| 37 | IONIS PHARMACEUTICALS INC | 91,000 | 4,353,000 | 0.89% | ||
| 38 | SHIRE PLC | 24,000 | 4,089,000 | 0.84% | ||
| 39 | MALLINCKRODT PUB LTD CO SHS | 80,800 | 4,025,000 | 0.82% | ||
| 40 | COOPER COS INC | 20,000 | 3,499,000 | 0.72% | ||
| 41 | EXPRESS SCRIPTS HLDG CO | 49,500 | 3,405,000 | 0.70% | ||
| 42 | MCKESSON CORP | 24,000 | 3,371,000 | 0.69% | ||
| 43 | EAGLE PHARMACEUTICALS INC COM | 40,700 | 3,229,000 | 0.66% | ||
| 44 | HUMANA | 15,500 | 3,162,000 | 0.65% | ||
| 45 | HALOZYME THERAPEUTICS INC | 318,000 | 3,142,000 | 0.64% | ||
| 46 | ULTRAGENYX PHARMACEUTICAL INC COM | 43,000 | 3,023,000 | 0.62% | ||
| 47 | ANTHEM INC | 20,600 | 2,962,000 | 0.61% | ||
| 48 | NEUROCRINE BIOSCIE COM USD0.001 | 75,000 | 2,902,000 | 0.59% | ||
| 49 | ZELTIQ AESTHETICS INCORPORATED | 60,000 | 2,611,000 | 0.53% | ||
| 50 | LILLY ELI & CO | 35,000 | 2,574,000 | 0.53% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-001410, filed 2017.02.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
